Plasma Rich in Growth Factors (PRGF) Treatment for Muscle Tear

PRP as a Treatment for Acute Muscle Tears - Randomized-double-blind-placebo Control Trail.

Status

Completed

Phases

Phase 2Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00726245

Enrollment

Registered

2008-07-31

Start date

2008-01-31

Completion date

2011-03-31

Last updated

2011-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle Tear

Brief summary

the improvement of symptoms and disease progress by the treatment of OA of the knee with PRGF

Interventions

BIOLOGICALPRGF

3-6mg IM (to area of muscle tear)

BIOLOGICALPlacebo

3cc IM of physiological saline

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

15 Years to 40 Years

Healthy volunteers

Inclusion criteria

* US diagnosed muscle tear * age 15-40 years old

Exclusion criteria

* pregnancy * mental or physical disabilities

Design outcomes

Primary

Measure	Time frame
improvement of symptoms / disease progress	1 year

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026